The CEO of Ford's profitable Pro business is retiring

Ted Cannis, Ford Pro CEO, speaks during an interview in New York, Thursday, July 28, 2022. Victor J. Blue |…

Gilead's lenacapavir reduced HIV infections by 96% in trial

A pharmacist holds a bottle of lenacapavir, the new injectable drug for HIV prevention. Nardus Engelbrecht | AP GileadPfizer's twice-yearly…